When we increased the FC used for common cases to 2 and performed subsequent analyses, the DEGs for MS patients without treatment were shown in Supplementary Table S10, and the DEGs for MS patients before and after the application of IFN-β or Fingolimod were shown in Supplementary Table S11. The gene discussed is IFNB1; the disease is myeloid sarcoma.